THE EXPRESSIONS OF PSA AND PCNA IN PROSTATIC CARCINOMA AND THEIR SIGNIFICANCE
Ping Zhang
Abstract
Ping Zhang
Abstract
ObjectiveTo study the features of expression of PSA and PCNA in prostatic carcinoma and benign prostatic hyperplasia(BPH). MethodsThe tissues of different-grade prostatic carcinoma in 44 cases and benign BPH in 20 cases were collected and stained by immunohistochemical method. The expressions of PSA and PCNA were observed.ResultsThe expression of PSA in BPH tissue was higher (16/20) than that in prostatic carcinoma samples (23/44), the difference was significant ( H=7.535, P0.05). With the increase of Gleason scores and clinical staging, PSA expression in the carcinoma declined (H= 7.031, 7.396, P0.05). The difference between PSA expression and serum-PSA level was not significant statistically (H= 0.653,P0.05). The expression of PCNA in carcinoma tissue was significantly higher than that in the BPH tissue (H=7.892, P0.05). The expression of PCNA increased with the increase of Gleason scores (H=6.502, P0.05). The difference of expressions of PCNA in different clinical stages showed no significance (H=2.345, P0.05).ConclusionThe expression of PSA and PCNA is related to the development and progression of prostatic carcinoma. [
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
ObjectiveTo study the features of expression of PSA and PCNA in prostatic carcinoma and benign prostatic hyperplasia(BPH). MethodsThe tissues of different-grade prostatic carcinoma in 44 cases and benign BPH in 20 cases were collected and stained by immunohistochemical method. The expressions of PSA and PCNA were observed.ResultsThe expression of PSA in BPH tissue was higher (16/20) than that in prostatic carcinoma samples (23/44), the difference was significant ( H=7.535, P0.05). With the increase of Gleason scores and clinical staging, PSA expression in the carcinoma declined (H= 7.031, 7.396, P0.05). The difference between PSA expression and serum-PSA level was not significant statistically (H= 0.653,P0.05). The expression of PCNA in carcinoma tissue was significantly higher than that in the BPH tissue (H=7.892, P0.05). The expression of PCNA increased with the increase of Gleason scores (H=6.502, P0.05). The difference of expressions of PCNA in different clinical stages showed no significance (H=2.345, P0.05).ConclusionThe expression of PSA and PCNA is related to the development and progression of prostatic carcinoma. [
Key concepts: Proliferating cell nuclear antigen, Medicine, Hyperplasia, Immunohistochemistry, Clinical significance, Carcinoma, Pathology, Prostate